DK462183A - Fremgangsmaade til fremstilling af 3-(heterocyclyl eller aryl)methylthio-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Fremgangsmaade til fremstilling af 3-(heterocyclyl eller aryl)methylthio-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf Download PDF

Info

Publication number
DK462183A
DK462183A DK462183A DK462183A DK462183A DK 462183 A DK462183 A DK 462183A DK 462183 A DK462183 A DK 462183A DK 462183 A DK462183 A DK 462183A DK 462183 A DK462183 A DK 462183A
Authority
DK
Denmark
Prior art keywords
triazol
heterocyclyl
methylthio
aryl
phenyl
Prior art date
Application number
DK462183A
Other languages
English (en)
Other versions
DK169178B1 (da
DK462183D0 (da
Inventor
Kelvin Cooper
Kenneth Richardson
Peter John Whittle
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK462183D0 publication Critical patent/DK462183D0/da
Publication of DK462183A publication Critical patent/DK462183A/da
Application granted granted Critical
Publication of DK169178B1 publication Critical patent/DK169178B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK462183A 1982-10-09 1983-10-07 Fremgangsmåde til fremstilling af 3-(heterocyclyl eller aryl)-methylthio-2-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf DK169178B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8228920 1982-10-09
GB8228920 1982-10-09

Publications (3)

Publication Number Publication Date
DK462183D0 DK462183D0 (da) 1983-10-07
DK462183A true DK462183A (da) 1984-04-10
DK169178B1 DK169178B1 (da) 1994-09-05

Family

ID=10533495

Family Applications (1)

Application Number Title Priority Date Filing Date
DK462183A DK169178B1 (da) 1982-10-09 1983-10-07 Fremgangsmåde til fremstilling af 3-(heterocyclyl eller aryl)-methylthio-2-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (7)

Country Link
US (1) US4505919A (da)
EP (1) EP0107392B1 (da)
JP (1) JPS5998072A (da)
DE (1) DE3377354D1 (da)
DK (1) DK169178B1 (da)
GR (1) GR79013B (da)
IE (1) IE56055B1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74431C (fi) * 1984-08-23 1988-02-08 Partek Ab Anordning foer lastning ett lastutrymme pao ett fordon och foer avlaegsning fraon det.
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
GB8701515D0 (en) * 1987-01-23 1987-02-25 Ici Plc Heterocyclic compounds
DE3835742A1 (de) * 1988-10-20 1990-05-10 Lentia Gmbh Neue nitroalkylazole
IE903395A1 (en) * 1989-09-26 1991-04-10 Takeda Chemical Industries Ltd Triazole compounds, their production and use
TW206224B (da) * 1989-12-14 1993-05-21 Takeda Pharm Industry Co Ltd
FR2656612B1 (fr) * 1989-12-28 1992-03-27 Rhone Poulenc Agrochimie Herbicides a groupe alcenyle ou heteroaryle thio, sulfone, sulfoxyde.
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
AU3735793A (en) * 1992-02-26 1993-09-13 Smithkline Beecham Corporation Retroviral protease inhibitors
US5239082A (en) * 1992-08-03 1993-08-24 Warner-Lambert Company Sulfonamide tetrazole ACAT inhibitors
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
CN1151138C (zh) * 1995-04-06 2004-05-26 三共株式会社 三唑抗真菌剂
IT1283038B1 (it) * 1996-02-28 1998-04-07 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario
US20100111881A1 (en) * 2006-01-27 2010-05-06 Xinyu Huang Polymeric anti-microbial agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036970A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
DE2735314A1 (de) * 1977-08-05 1979-02-22 Basf Ag Alpha-azolylsulfide und deren derivate
DE2821829A1 (de) * 1978-05-19 1979-11-22 Basf Ag Mittel zur regulierung des pflanzenwachstums
DE2908378A1 (de) * 1979-03-03 1980-09-11 Hoechst Ag Derivate des 1,2,4-triazols
DE2926096A1 (de) * 1979-06-28 1981-01-08 Basf Ag Fungizide beta -triazolylether, ihre herstellung und verwendung
AU542623B2 (en) * 1980-05-16 1985-02-28 Bayer Aktiengesellschaft 1-hydroxyethyl-azole derivatives
EP0046633A1 (en) * 1980-08-22 1982-03-03 Imperial Chemical Industries Plc Heterocyclic compounds useful as pesticides and processes for making them
DE3048267A1 (de) * 1980-12-20 1982-07-15 Bayer Ag, 5090 Leverkusen Substituierte 1-azolyl-butan-2-ole, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel sowie als zwischenprodukte
CA1162540A (en) * 1980-12-24 1984-02-21 Ikutaro Saji Imidazolylpropanol compounds and their acid addition salts, and production and use thereof
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them

Also Published As

Publication number Publication date
US4505919A (en) 1985-03-19
JPS6346069B2 (da) 1988-09-13
GR79013B (da) 1984-10-02
EP0107392B1 (en) 1988-07-13
IE832361L (en) 1984-04-09
EP0107392A1 (en) 1984-05-02
DE3377354D1 (en) 1988-08-18
DK169178B1 (da) 1994-09-05
DK462183D0 (da) 1983-10-07
IE56055B1 (en) 1991-03-27
JPS5998072A (ja) 1984-06-06

Similar Documents

Publication Publication Date Title
DK252282A (da) Fremgangsmaade til fremstilling af 1,3-bis-(1,2,4-triazol-1-yl)-2-(2,4-difluorphenyl)propan-2-ol eller far aceutisk acceptable salte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK337383A (da) Fremgangsmaade til fremstilling af 4-amino-6,7-dimethoxyquinolin-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK106882A (da) Fremgangsmaade til fremstilling af 3,4-dihydro-5h-2,3-benzodiazepin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK462183D0 (da) Fremgangsmade til fremstilling af 3-(heterocyclyl eller aryl)methylthio-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-propanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK405881A (da) Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK148795C (da) Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK413783A (da) Fremgangsmaade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK453181A (da) Fremgangsmaade til fremstilling af 2-quanidino-4-heteroaryl-thiazolforbindelser eller syreadditionssalte deraf
DK45081A (da) Fremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl) )--imidazolin eller ikke-toxiske syreadditionssalte deraf
DK287380A (da) Fremgangsmaade til fremstilling af 2-phenyl-2-hydroxy-1-(1-imidazolyl)alkan- eller- alkenforbindelser eller syreadditionssalte deraf
DK77880A (da) Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf
DK98383A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK275383A (da) Fremgangsmaade til fremstilling af 1-(2-heterocyclyl-2-(5-chlor-2-pyridyl)-2-hydroxy-ethyl)-1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK533881A (da) Fremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxidazol-2-oxider eller farmekologisk acceptable syreadditionsforbindelser
DK154216C (da) Analogifremgangsmaade til fremstilling af 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanoner eller syreadditionssalte deraf
DK157928C (da) Analogifremgangsmaade til fremstilling af 2-amino-2-phenyl-1,3-bis(1h-1,2,4-triazol-1-yl)propan-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK152754C (da) Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK386882A (da) Fremgangsmaade til fremstilling af 5'-(2-amino-4-pyridyl)-1',2',4'-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK357683D0 (da) Fremgangsmade til fremstilling af 1-(5-chlorpyrid-2-yl)-1-(2,4-dihalogenphenyl)-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller deres farmaceutisk acceptable syreadditionssalte
DK234182A (da) Fremgangsmaade til fremstilling af heterocyclisk substitueredeamidoximer eller syreadditionssalte deraf
DK398283A (da) Fremgangsmaade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK151021C (da) Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf